In addition, Kornspan et al. found that overexpression of TLE3 but not TLE1 enhanced non-small cell lung cancer (NSCLC) cell line sensitivity to taxane treatment (Kornspan et al., 2021). This evidence concerns the gene TLE3 and non-small cell lung carcinoma.